Editorial: Gene Expression Profile Assays As an Aid in Treatment Decision Making in Early-stage Breast Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Simon R, Radmacher M, Dobbin K, McShane L
. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst. 2003; 95(1):14-8.
DOI: 10.1093/jnci/95.1.14.
View
2.
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M
. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004; 351(27):2817-26.
DOI: 10.1056/NEJMoa041588.
View
3.
Lyman G, Kuderer N
. Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis. Clin Breast Cancer. 2007; 7(5):372-9.
DOI: 10.3816/CBC.2006.n.053.
View
4.
Fisher B, Jeong J, Bryant J, Anderson S, Dignam J, Fisher E
. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet. 2004; 364(9437):858-68.
DOI: 10.1016/S0140-6736(04)16981-X.
View
5.
Paik S, Tang G, Shak S, Kim C, Baker J, Kim W
. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006; 24(23):3726-34.
DOI: 10.1200/JCO.2005.04.7985.
View